WHO ICTRP trial
Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes of Catheter…
JPRN-UMIN000055056 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000055056 |
|---|---|
| Public title | Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes of Catheter Ablation for Atrial Fibrillation in Heart Failure Patients without Type-2 Diabetes. |
| Scientific title | Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes of Catheter Ablation for Atrial Fibrillation in Heart Failure Patients without Type-2 Diabetes. - NODACH-SGLT2 Study |
| Primary sponsor | Fujita Health University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Heart failure and persistent atrial fibrillation patients without type-2 diabetes |
| Interventions | Treatment arm: patients were to receive sodium-glucose cotransporter 2 inhibitors (SGLT2is) for more than one month prior to catheter ablation and were continued during 1-year follow-up. Control arm: patients were observed without SGLT2is… |
| Registration date | Jul 24, 2024 |
| Target size | 110 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: